论文部分内容阅读
乳腺癌预防研究(BCDT)系在乳腺癌高危险性的正常妇女中检验用抗孕激素药物三苯氧胺预防冠心病和乳腺癌发生有效性的大规模、多中心的化学药物干预研究。BCPT是在乳腺癌早期阶段用三苯氧胺预防复发和对侧乳腺癌证明有效的基础上发展起来的。本文的目的是描述在BCRT研究中与健康相关的生活质量(HRQL)资料的收集方法,对BCRT研究的9749例首次参加者提出HRQL的基线标准。HRQL问卷包括抑郁标准的流行病研
The Breast Cancer Prevention Study (BCDT) is a large-scale, multicenter, chemical-drug intervention study that examines the effectiveness of the antiprogestin drug Tamoxifen in the prevention of coronary heart disease and breast cancer in normal high-risk breast cancer women. BCPT was developed based on the proven efficacy of tamoxifen in the early stages of breast cancer to prevent recurrence and contralateral breast cancer. The purpose of this article is to describe the collection of health-related quality of life (HRQL) data in the BCRT study. The baseline criteria for HRQL were proposed for the 9 799 first-time participants in the BCRT study. The HRQL questionnaire includes epidemiological studies of depression criteria